130 related articles for article (PubMed ID: 38591255)
1. A mitochondria-targeting heptamethine cyanine-chlorambucil formulated polymeric nanoparticle to potentiate native tumor chemotherapeutic efficacy.
Liu J; Zhang J; Zhang Y; Wei W; Zhan M; Zhang Z; Liu B; Hu X; He W
Biomater Sci; 2024 May; 12(10):2614-2625. PubMed ID: 38591255
[TBL] [Abstract][Full Text] [Related]
2. Phototheranostic nanoplatform based on a single cyanine dye for image-guided combinatorial phototherapy.
Duong T; Li X; Yang B; Schumann C; Albarqi HA; Taratula O; Taratula O
Nanomedicine; 2017 Apr; 13(3):955-963. PubMed ID: 27884637
[TBL] [Abstract][Full Text] [Related]
3. Dye-loaded mesoporous polydopamine nanoparticles for multimodal tumor theranostics with enhanced immunogenic cell death.
Tian Y; Younis MR; Tang Y; Liao X; He G; Wang S; Teng Z; Huang P; Zhang L; Lu G
J Nanobiotechnology; 2021 Nov; 19(1):365. PubMed ID: 34789274
[TBL] [Abstract][Full Text] [Related]
4. Peptide-Driven Targeted Drug-Delivery System Comprising Turn-On Near-Infrared Fluorescent Xanthene-Cyanine Reporter for Real-Time Monitoring of Drug Release.
Ebaston TM; Rozovsky A; Zaporozhets A; Bazylevich A; Tuchinsky H; Marks V; Gellerman G; Patsenker LD
ChemMedChem; 2019 Oct; 14(19):1727-1734. PubMed ID: 31403246
[TBL] [Abstract][Full Text] [Related]
5. A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer.
Pathak RK; Wen R; Kolishetti N; Dhar S
Mol Cancer Ther; 2017 Apr; 16(4):625-636. PubMed ID: 28148716
[TBL] [Abstract][Full Text] [Related]
6. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
7. MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent.
Thomas RG; Moon MJ; Surendran SP; Park HJ; Park IK; Lee BI; Jeong YY
Mol Imaging Biol; 2018 Aug; 20(4):533-543. PubMed ID: 29450802
[TBL] [Abstract][Full Text] [Related]
8. Structural modifications of mitochondria-targeted chlorambucil alter cell death mechanism but preserve MDR evasion.
Jean SR; Pereira MP; Kelley SO
Mol Pharm; 2014 Aug; 11(8):2675-82. PubMed ID: 24922525
[TBL] [Abstract][Full Text] [Related]
9. Achieving traceless ablation of solid tumors without recurrence by mild photothermal-chemotherapy of triple stimuli-responsive polymer-drug conjugate nanoparticles.
Du C; Ding Y; Qian J; Zhang R; Dong CM
J Mater Chem B; 2019 Jan; 7(3):415-432. PubMed ID: 32254729
[TBL] [Abstract][Full Text] [Related]
10. Design of a Novel Theranostic Nanomedicine (III): Synthesis and Physicochemical Properties of Tumor-Targeting Cisplatin Conjugated to a Hydrophilic Polyphosphazene.
Patil BR; Kang SY; Jung DH; Avaji PG; Jun YJ; Lee HJ; Sohn YS
Int J Nanomedicine; 2020; 15():981-990. PubMed ID: 32103951
[TBL] [Abstract][Full Text] [Related]
11. Dual-Mode Imaging Guided Multifunctional Theranosomes with Mitochondria Targeting for Photothermally Controlled and Enhanced Photodynamic Therapy in Vitro and in Vivo.
Wang S; Guo F; Ji Y; Yu M; Wang J; Li N
Mol Pharm; 2018 Aug; 15(8):3318-3331. PubMed ID: 29975536
[TBL] [Abstract][Full Text] [Related]
12. Cyanine-Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells.
Jiang Z; Pflug K; Usama SM; Kuai D; Yan X; Sitcheran R; Burgess K
J Med Chem; 2019 Oct; 62(20):9236-9245. PubMed ID: 31469566
[TBL] [Abstract][Full Text] [Related]
13. A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers.
Millard M; Gallagher JD; Olenyuk BZ; Neamati N
J Med Chem; 2013 Nov; 56(22):9170-9. PubMed ID: 24147900
[TBL] [Abstract][Full Text] [Related]
14. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
[TBL] [Abstract][Full Text] [Related]
15. Targeted combinational therapy inducing mitochondrial dysfunction.
Shin WS; Park SK; Verwilst P; Koo S; Lee JH; Chi SG; Kim JS
Chem Commun (Camb); 2017 Jan; 53(7):1281-1284. PubMed ID: 28067351
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled heptamethine cyanine dye dimer as a novel theranostic drug delivery carrier for effective image-guided chemo-photothermal cancer therapy.
Jeong C; Uthaman S; Bagheri B; Kim J; Pillarisetti S; Park IK; Kim YC
J Control Release; 2021 Jan; 329():50-62. PubMed ID: 33259849
[TBL] [Abstract][Full Text] [Related]
17. Novel molecular anti-colorectalcancer conjugate:chlorambucil-adipic acid dihydrizide-glutamine.
Tabasi MA; Amanlou M; Siadat SD; Nourmohammadi Z; Omoomi FD; Ebrahimi SE; Aghasadeghi MR; Rahimi P; Pourhosseini S; Mehravi B; Ardestani MS
Anticancer Agents Med Chem; 2013 Nov; 13(9):1449-59. PubMed ID: 23343080
[TBL] [Abstract][Full Text] [Related]
18. Improving Therapeutic Potential of Farnesylthiosalicylic Acid: Tumor Specific Delivery via Conjugation with Heptamethine Cyanine Dye.
Guan Y; Zhang Y; Xiao L; Li J; Wang JP; Chordia MD; Liu ZQ; Chung LW; Yue W; Pan D
Mol Pharm; 2017 Jan; 14(1):1-13. PubMed ID: 26992462
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria targeting and near-infrared fluorescence imaging of a novel heptamethine cyanine anticancer agent.
Ning J; Huang B; Wei Z; Li W; Zheng H; Ma L; Xing Z; Niu H; Huang W
Mol Med Rep; 2017 Jun; 15(6):3761-3766. PubMed ID: 28440435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
